Testing the Capability of the Smart Underwear Device to Detect Increased Microbiome Activity Following Lactose Consumption
1 other identifier
interventional
37
1 country
1
Brief Summary
The goal of this Interventional study is to validate the Smart Underwear device's ability to detect lactose intolerance by comparing its results to self-reported symptoms in adult participants aged 18 and above, divided equally between self-reported lactose-tolerant and lactose-intolerant individuals. The main questions it aims to answer are: Can the Smart Underwear device reliably measure flatus events after lactose consumption? Does the Microbiome Activity Index differentiate between responses to lactose and sucrose consumption? Researchers will compare participants consuming lactose (experimental arm) with their results after consuming sucrose (placebo arm) to see if the device detects increased flatus events and higher Microbiome Activity Index values in the lactose arm. Participants will:
- Follow a low-fiber/low-FODMAP diet for four days.
- Record meals using a food log and a custom smartphone app.
- Wear the Smart Underwear device for 8 hours daily for three days.
- Fast for 12 hours overnight, consume 20 grams of either lactose or sucrose dissolved in water, and continue fasting for an additional 4 hours.
- Fast for 12 hours overnight, consume 20 grams of the carbohydrate they did not consume the first time (lactose or sucrose) dissolved in water, and continue fasting for an additional 4 hours.
- Complete digestive symptom surveys after each carbohydrate intake. The randomized crossover design ensures that participants consume both lactose and sucrose on separate days, with blinding maintained for both participants and researchers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2024
CompletedStudy Start
First participant enrolled
December 5, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedMay 1, 2026
April 1, 2026
1.2 years
November 25, 2024
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Microbiome activity index
The Microbiome Activity Index A high gut microbiome activity is closely correlated with hydrogen gas production, reflected in the increase of both flatus frequency and hydrogen concentration. It is essential to consider these two variables together. The accumulated gas can be expelled in a few high-intensity events or through a series of smaller flatus. Consequently, relying solely on counting flatus or measuring only the sensor output does not provide a complete picture of gut microbiome activity. Additionally, the investigators found that high concentrations of hydrogen in flatus can sometimes saturate the sensor. To address this issue, the investigators discovered that using the absolute value of the sensor signal's first derivative offers a more accurate assessment of flatus intensity. By measuring the rate of change rather than the signal output, the method can reduce the baseline contribution and better identify flatus.
8 hours from consumption of the lactose and sucrose
Study Arms (2)
Placebo
PLACEBO COMPARATORParticipants consume sucrose and wear the Smart Underwear device
Experimental
EXPERIMENTALParticipants consume lactose and wear the Smart Underwear device
Interventions
Participants receive lactose to determine whether it changes gut microbial hydrogen production
Participants will consume sucrose which they will consume as a placebo
Participants will wear the smart underwear device to measure the microbiome activity index
Eligibility Criteria
You may qualify if:
- Has no gastrointestinal disorders
- Not consuming any prescribed medications
- Willing and able to consume sucrose and lactose
- Determined to be lactose tolerant or lactose intolerant after completing an eligibility survey
You may not qualify if:
- Younger than 18 years old
- Diagnosed with or suspected to have the following conditions: diabetes, prediabetes, high blood sugar, IBD, SIBO, or a food allergy to sucrose or lactose
- Experience gastrointestinal pain, bloating, or diarrhea when consuming garlic, onions, or leeks
- Routinely experience constipation or painful constipation
- Have ever had an anaphylactic reaction after eating or drinking anything
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bioscience Research Building
College Park, Maryland, 20742, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2024
First Posted
December 9, 2024
Study Start
December 5, 2024
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
The following Individual Participant Data (IPD) will be shared: Microbiome Activity Index measurements from both the sham control and lactose challenge arms, collected via the Smart Underwear device's electrochemical sensor array during the controlled crossover trial. The Microbiome Activity Index reflects the quantified hydrogen gas events exceeding baseline threshold during the monitoring period. The study protocol and informed consent documents will also be made available. The data represents measurements taken over 8-hour periods following oral lactose or sham administration while participants wore the device.